---
access_model:
  confidence: medium
  label: Open access
  onboarding: open
  pricing: unknown
  public: true
  source:
  - authentication
  - rate-limits
  - security
  trial: false
  try_now: false
agent_readiness:
  band: agent-aware
  dimensions:
    agent_card: false
    agent_skills: derived
    agentic_access: false
    agentic_commerce: false
    auth_clarity: bearer
    consent_identity: false
    delegated_identity: false
    dry_run_mode: false
    dynamic_client_registration: false
    error_semantics: documented
    event_surface_described: false
    idempotency: false
    mcp_server: false
    openapi_examples: partial
    protected_resource_metadata: false
    rate_limit_signal: documented
    reversibility_documented: false
    spec_presence: true
    well_known_catalog: false
  schema_version: 0.2
  score: 24.3
  scored_at: '2026-09-02'
api_count: 10
apis:
- baseURL: https://momatx.com/wp-json
  baseurl_source: declared
  description: News archive — company press releases, media coverage, peer-reviewed publications and conference presentations (32 published at harvest time, spanning April 2020 through August 2026).
  name: MOMA Therapeutics Content Posts API
  slug: moma-therapeutics-posts-api
- baseURL: https://momatx.com/wp-json
  baseurl_source: declared
  description: Corporate pages — Science, Pipeline, MOMA, Team, Join Us, News Feed, Privacy Policy and Terms (9 published at harvest time). The acf.modules flexible-content array carries the page-builder blocks that
  name: MOMA Therapeutics Content Pages API
  slug: moma-therapeutics-pages-api
- baseURL: https://momatx.com/wp-json
  baseurl_source: declared
  description: The team custom post type — leadership, board of directors, scientific advisory board and founders (59 published records at harvest time), classified by the MOMA-specific team_types taxonomy and carry
  name: MOMA Therapeutics Team API
  slug: moma-therapeutics-team-api
- baseURL: https://momatx.com/wp-json
  baseurl_source: declared
  description: Media library — AACR conference posters, publication PDFs, headshots, logos and site imagery (211 attachments at harvest time).
  name: MOMA Therapeutics Media API
  slug: moma-therapeutics-media-api
- baseURL: https://momatx.com/wp-json
  baseurl_source: declared
  description: Term collections for the three registered taxonomies — category (4 terms including Blog and Press Release), post_tag (registered but empty) and the MOMA-specific team_types (3 terms including Founders
  name: MOMA Therapeutics Taxonomy API
  slug: moma-therapeutics-taxonomy-api
- baseURL: https://momatx.com/wp-json
  baseurl_source: declared
  description: Self-describing metadata — the 219-route index across 12 namespaces, plus registered post types, taxonomies and statuses. This is the only machine-readable contract the company serves.
  name: MOMA Therapeutics Discovery API
  slug: moma-therapeutics-discovery-api
- baseURL: https://momatx.com/wp-json
  baseurl_source: declared
  description: Cross-content search over every published object — posts, pages and team records. An unfiltered query returned 42 results at harvest time.
  name: MOMA Therapeutics Search API
  slug: moma-therapeutics-search-api
- baseURL: https://momatx.com/wp-json
  baseurl_source: declared
  description: Comment collection. Registered and anonymously reachable, but empty — no object on this deployment carries comments.
  name: MOMA Therapeutics Comments API
  slug: moma-therapeutics-comments-api
- baseURL: https://momatx.com/wp-json
  baseurl_source: declared
  description: oEmbed 1.0 provider endpoint for momatx.com URLs, returning rich embeddable responses.
  name: MOMA Therapeutics oEmbed API
  slug: moma-therapeutics-oembed-api
- baseURL: https://momatx.com/wp-json
  baseurl_source: declared
  description: Advanced Custom Fields options-page payload, anonymously readable at /acf/v3/options/options. It carries site-wide configuration — logo, footer contact block, social profile URLs, copyright line and v
  name: MOMA Therapeutics Site Options API
  slug: moma-therapeutics-options-api
artifact_total: 14
common:
- group: company
  title: ''
  type: Website
  url: https://momatx.com/
- group: company
  title: ''
  type: About
  url: https://momatx.com/moma/
- group: other
  title: ''
  type: Science
  url: https://momatx.com/science/
- group: other
  title: ''
  type: Pipeline
  url: https://momatx.com/pipeline/
- group: other
  title: ''
  type: Team
  url: https://momatx.com/team/
- group: company
  title: ''
  type: News
  url: https://momatx.com/news-feed/
- group: company
  title: ''
  type: Blog
  url: https://momatx.com/posts/category/blog/
- group: company
  title: ''
  type: BlogRSS
  url: https://momatx.com/feed/
- group: operate
  title: ''
  type: PressReleases
  url: https://momatx.com/posts/category/press-release/
- group: company
  title: ''
  type: Careers
  url: https://momatx.com/join-us/
- group: commercial
  title: ''
  type: PrivacyPolicy
  url: https://momatx.com/privacy-policy/
- group: commercial
  title: ''
  type: TermsOfService
  url: https://momatx.com/terms/
- group: company
  title: ''
  type: LinkedIn
  url: https://www.linkedin.com/company/momatx
- group: company
  title: ''
  type: Twitter
  url: https://twitter.com/moma_tx
- group: learn
  title: ''
  type: YouTube
  url: https://www.youtube.com/channel/UCqBg_d0f0IqXUDbzADjcI1g
- group: other
  title: ''
  type: SecondaryMarket
  url: https://forgeglobal.com/moma-therapeutics_stock/
- group: auth
  title: ''
  type: Authentication
  url: authentication/moma-therapeutics-authentication.yml
- group: design
  title: ''
  type: Conventions
  url: conventions/moma-therapeutics-conventions.yml
- group: design
  title: ''
  type: Conformance
  url: conformance/moma-therapeutics-conformance.yml
- group: design
  title: ''
  type: ErrorCatalog
  url: errors/moma-therapeutics-problem-types.yml
- group: design
  title: ''
  type: Lifecycle
  url: lifecycle/moma-therapeutics-lifecycle.yml
- group: design
  title: ''
  type: DataModel
  url: data-model/moma-therapeutics-data-model.yml
- group: build
  title: ''
  type: Packages
  url: packages/moma-therapeutics-packages.yml
- group: auth
  title: ''
  type: DomainSecurity
  url: security/moma-therapeutics-domain-security.yml
- group: operate
  title: ''
  type: RateLimits
  url: rate-limits/moma-therapeutics-rate-limits.yml
- group: commercial
  title: ''
  type: Plans
  url: plans/moma-therapeutics-plans-pricing.yml
- group: agent
  title: ''
  type: LLMsTxt
  url: llms/moma-therapeutics-llms.txt
- group: agent
  title: ''
  type: AgentSkill
  url: skills/_index.yml
created: '2026-08-26'
description: 'MOMA Therapeutics is a Cambridge, Massachusetts drug-discovery company founded in 2020 that builds precision medicines against molecular machines — the highly dynamic proteins that convert chemical energy stored in cells into regulatory work such as protein transport, DNA repair and degradation, and whose constant conformational shape-shifting has historically made them undruggable. Its proprietary KNOMATIC platform combines advanced structural frameworks and functional-genomics target validation with high-throughput fragment and DNA-encoded-library screening, CRISPR gene editing, artificial intelligence for detecting dynamic conformational patterns, and machine-learning lead optimisation, all built against a continually expanding structure-function knowledge base. The company launched in April 2020 with an $86 million Series A led by Third Rock Ventures, added a $150 million Series B in May 2022, and has taken two wholly owned oncology assets into the clinic: MOMA-313, a selective
  inhibitor of the polymerase theta (Polθ) helicase domain for homologous- recombination-deficient tumours, which entered Phase 1 in August 2024; and MOMA-341, a potent and selective WRN helicase inhibitor for microsatellite-unstable and TA-repeat-expanded tumours, which dosed its first Phase 1 patient in July 2025. It also runs a five-year discovery collaboration with Roche announced in January 2024, an oncology collaboration and licence agreement with Bayer signed in October 2024, and an exclusive licence for a selective PARP1 inhibitor announced in January 2025. MOMA Therapeutics runs no developer program and publishes no product API, developer portal, API reference or machine-readable specification. The only machine-readable surface reachable without credentials is the WordPress REST content API behind momatx.com, catalogued here.'
image: https://momatx.com/wp-content/uploads/2025/03/logo-moma.png
layout: provider
modified: '2026-08-26'
name: MOMA Therapeutics
nav: Providers
network: true
overview: 'MOMA Therapeutics publishes 10 APIs on the [APIs.io](https://apis.io/) network, including Content Posts API, Content Pages API, Team API, and 7 more. Tagged areas include Company, Biotechnology, Pharmaceuticals, Drug Discovery, and Oncology.


  MOMA Therapeutics'' developer surface includes product news, engineering blog, YouTube channel, authentication, and 24 more developer resources.'
plans:
- name: Moma Therapeutics Plans Pricing
  plan_count: 0
  slug: moma-therapeutics-plans-pricing
random_paper: 4
rate_limits:
- limit_count: 0
  name: Moma Therapeutics Rate Limits
  slug: moma-therapeutics-rate-limits
score:
  band: thin
  composite: 32.3
  coverage:
    artifact_dirs: 18
    catalog_gap: 75.0
    catalog_max: 115.0
    note: Disclosure, not a penalty. catalog_gap is rubric points API Evangelist could add with no action by this provider; it is our backlog, not their gap, and it is NOT subtracted from the composite above.
  delta: 0.0
  facets:
    access_clarity: 21.1
    commercial_clarity: 21.1
    contract_governance: 18.2
    contract_quality: 53.4
    developer_ergonomics: 16.1
    discoverability: 74.1
    governance: 18.2
    operational_transparency: 0.0
  previous_composite: 32.3
  provenance:
    conformance: first-party
    contracts:
      callable: 100.0
      derived: 0
      marker_coverage: 0.0
      total: 10
    mcp: derived
    skills: derived
  regulatory:
    applies: true
    matched_via: tags
    regime: Health
    regime_id: health
    score: 31.3
  schema_version: 0.18.0
  scored_at: '2026-09-02'
  trend: flat
screenshot: https://raw.githubusercontent.com/api-evangelist/moma-therapeutics/refs/heads/main/screenshots/moma-therapeutics-2026-09-02T150619.png
security:
- kind: authentication
  name: Moma Therapeutics Authentication
  slug: moma-therapeutics-authentication
  summary_line: 0 schemes
- kind: domain-security
  name: Moma Therapeutics Domain Security
  slug: moma-therapeutics-domain-security
  summary_line: TLSv1.3 · DMARC
slug: moma-therapeutics
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Drug Discovery
- Oncology
- Precision Medicine
- Life Sciences
- Structural Biology
- Machine-Learning
- content-api
website: https://momatx.com/
---
